These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11705627)

  • 1. Latent HSV 1 virus in trigeminal ganglia: the optimal site for linking prevention of Alzheimer's disease to vaccination.
    Ball MJ; Mathews R; Steiner I; Hill JM; Wisner TW; Murdoch GH; Kohama S; Sexton G; Nagalla S
    Neurobiol Aging; 2001; 22(5):705-9; discussion 717-9. PubMed ID: 11705627
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential for HSV-1 vaccination to reduce risk of HSV-1 encephalitis and/or Alzheimer's disease?
    Esiri MM
    Neurobiol Aging; 2001; 22(5):711-3; discussion 717-9. PubMed ID: 11705628
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease and herpes.
    Itzhaki RF; Dobson CB
    CMAJ; 2002 Jul; 167(1):13. PubMed ID: 12137067
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination prevents latent HSV1 infection of mouse brain.
    Lin WR; Jennings R; Smith TL; Wozniak MA; Itzhaki RF
    Neurobiol Aging; 2001; 22(5):699-703. PubMed ID: 11705626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Herpes simplex virus type 1 as risk factor associated to Alzheimer disease].
    Martin C; Solís L; Concha MI; Otth C
    Rev Med Chil; 2011 Jun; 139(6):779-86. PubMed ID: 22051760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How plausible is a link between HSV-1 infection and Alzheimer's disease?
    Agostini S; Clerici M; Mancuso R
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):275-8. PubMed ID: 24502805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are latent, immediate-early genes of herpes simplex virus-1 essential in causing trigeminal neuralgia?
    Ecker AD; Smith JE
    Med Hypotheses; 2002 Nov; 59(5):603-6. PubMed ID: 12376087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.
    Augustinova H; Hoeller D; Yao F
    J Virol; 2004 Jun; 78(11):5756-65. PubMed ID: 15140973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 1 and Alzheimer's disease: link and potential impact on treatment.
    Mancuso R; Sicurella M; Agostini S; Marconi P; Clerici M
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):715-731. PubMed ID: 31414935
    [No Abstract]   [Full Text] [Related]  

  • 10. A protective role for herpes simplex virus type-1-specific humoral immunity in Alzheimer's Disease.
    Agostini S; Mancuso R; Baglio F; Clerici M
    Expert Rev Anti Infect Ther; 2017 Feb; 15(2):89-91. PubMed ID: 27882822
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of immunization on herpes simplex virus type 1 latent infection in the trigeminal ganglion.
    Kramer M; Riley J; Spoering A; Coen D; Knipe D
    Curr Eye Res; 2003; 26(3-4):185-94. PubMed ID: 12815546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients.
    Wozniak MA; Shipley SJ; Combrinck M; Wilcock GK; Itzhaki RF
    J Med Virol; 2005 Feb; 75(2):300-6. PubMed ID: 15602731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of Herpes Simplex Virus Reactivation Suggests a Mechanism of Trigeminal Neuralgia Surgical Efficacy.
    Tenser RB
    World Neurosurg; 2015 Aug; 84(2):279-82. PubMed ID: 25818891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection.
    Ghiasi H; Cai S; Nesburn AB; Wechsler SL
    Virology; 1996 Oct; 224(1):330-3. PubMed ID: 8862430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trigeminal neuralgia: mechanisms of treatment.
    Tenser RB
    Neurology; 1998 Jul; 51(1):17-9. PubMed ID: 9674772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease.
    Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and infection: Do infectious agents contribute to progression of Alzheimer's disease?
    Itzhaki RF; Wozniak MA
    Alzheimers Dement; 2010 Jan; 6(1):83-4; author reply 85. PubMed ID: 20129323
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunobiology of herpes simplex virus (HSV) infections.
    Corey L
    Herpes; 2001 Mar; 8 Suppl 1():1A. PubMed ID: 11867026
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential prophylactic and therapeutic vaccines for HSV infections.
    Ramachandran S; Kinchington PR
    Curr Pharm Des; 2007; 13(19):1965-73. PubMed ID: 17627530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.